Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bone Metastases
Related studies linked through entity extraction aliases.
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation
- Status
- COMPLETED
- Phase
- PHASE1
Concurrent Xeloda and Radiotherapy for Bone Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
- Status
- COMPLETED
- Phase
- PHASE1